Dr. Chughtai explains how "less is more" approach has implications for BPH

As the year comes to a close, we revisit some of this year’s top content on benign prostatic hyperplasia in urology.

The data were presented at the recent American Urological Association Annual Meeting.

The center will offer a comprehensive range of treatments, including prostate artery embolization for men suffering from benign prostatic hyperplasia with very large prostates.

“Even though there [are] many therapies that one can do, it's not a sign of anything ominous for most men,” says Kevin T. McVary, MD, FACS.

The inclusion of iTind is reflected in a newly added statement on temporary implanted prostatic devices.

Both the LUTS/BPH and testicular cancer guidelines were updated based on the availability of new literature, as identified through an AUA Update Literature Review process.